287 related articles for article (PubMed ID: 17426256)
21. New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo.
Petitclerc E; Boutaud A; Prestayko A; Xu J; Sado Y; Ninomiya Y; Sarras MP; Hudson BG; Brooks PC
J Biol Chem; 2000 Mar; 275(11):8051-61. PubMed ID: 10713126
[TBL] [Abstract][Full Text] [Related]
22. Oncothanin, a peptide from the alpha3 chain of type IV collagen, modifies endothelial cell function and inhibits angiogenesis.
Shahan T; Grant D; Tootell M; Ziaie Z; Ohno N; Mousa S; Mohamad S; Delisser H; Kefalides N
Connect Tissue Res; 2004; 45(3):151-63. PubMed ID: 15512769
[TBL] [Abstract][Full Text] [Related]
23. Distinct antitumor properties of a type IV collagen domain derived from basement membrane.
Maeshima Y; Colorado PC; Torre A; Holthaus KA; Grunkemeyer JA; Ericksen MB; Hopfer H; Xiao Y; Stillman IE; Kalluri R
J Biol Chem; 2000 Jul; 275(28):21340-8. PubMed ID: 10766752
[TBL] [Abstract][Full Text] [Related]
24. FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by alpha1(IV)NC1.
Boosani CS; Nalabothula N; Munugalavadla V; Cosgrove D; Keshamoun VG; Sheibani N; Sudhakar A
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4567-75. PubMed ID: 19443723
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of elastin peptide-mediated angiogenic signaling mechanism(s) in choroidal endothelial cells by the α6(IV)NC1 collagen fragment.
Gunda V; Verma RK; Sudhakar YA
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):7828-35. PubMed ID: 24194191
[TBL] [Abstract][Full Text] [Related]
26. Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo.
Roth JM; Akalu A; Zelmanovich A; Policarpio D; Ng B; MacDonald S; Formenti S; Liebes L; Brooks PC
Am J Pathol; 2005 Mar; 166(3):901-11. PubMed ID: 15743801
[TBL] [Abstract][Full Text] [Related]
27. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.
Rüegg C; Dormond O; Mariotti A
Biochim Biophys Acta; 2004 Mar; 1654(1):51-67. PubMed ID: 14984767
[TBL] [Abstract][Full Text] [Related]
28. Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice.
Steri V; Ellison TS; Gontarczyk AM; Weilbaecher K; Schneider JG; Edwards D; Fruttiger M; Hodivala-Dilke KM; Robinson SD
Circ Res; 2014 Jan; 114(1):79-91. PubMed ID: 24103390
[TBL] [Abstract][Full Text] [Related]
29. Integrin α3β1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonization.
Varzavand A; Drake JM; Svensson RU; Herndon ME; Zhou B; Henry MD; Stipp CS
Clin Exp Metastasis; 2013 Apr; 30(4):541-52. PubMed ID: 23224938
[TBL] [Abstract][Full Text] [Related]
30. Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells: which side to target?
Rüegg C; Dormond O; Foletti A
Endothelium; 2002; 9(3):151-60. PubMed ID: 12380640
[TBL] [Abstract][Full Text] [Related]
31. Keratinocyte Integrin α3β1 Promotes Secretion of IL-1α to Effect Paracrine Regulation of Fibroblast Gene Expression and Differentiation.
Zheng R; Longmate WM; DeFreest L; Varney S; Wu L; DiPersio CM; Van De Water L
J Invest Dermatol; 2019 Sep; 139(9):2029-2038.e3. PubMed ID: 30878678
[TBL] [Abstract][Full Text] [Related]
32. Implication of tumstatin in tumor progression of human bronchopulmonary carcinomas.
Caudroy S; Cucherousset J; Lorenzato M; Zahm JM; Martinella-Catusse C; Polette M; Birembaut P
Hum Pathol; 2004 Oct; 35(10):1218-22. PubMed ID: 15492988
[TBL] [Abstract][Full Text] [Related]
33. Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
Belvisi L; Riccioni T; Marcellini M; Vesci L; Chiarucci I; Efrati D; Potenza D; Scolastico C; Manzoni L; Lombardo K; Stasi MA; Orlandi A; Ciucci A; Nico B; Ribatti D; Giannini G; Presta M; Carminati P; Pisano C
Mol Cancer Ther; 2005 Nov; 4(11):1670-80. PubMed ID: 16275988
[TBL] [Abstract][Full Text] [Related]
34. The NC1 domain of type XIX collagen inhibits in vivo melanoma growth.
Ramont L; Brassart-Pasco S; Thevenard J; Deshorgue A; Venteo L; Laronze JY; Pluot M; Monboisse JC; Maquart FX
Mol Cancer Ther; 2007 Feb; 6(2):506-14. PubMed ID: 17308049
[TBL] [Abstract][Full Text] [Related]
35. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism.
Seo DW; Li H; Guedez L; Wingfield PT; Diaz T; Salloum R; Wei BY; Stetler-Stevenson WG
Cell; 2003 Jul; 114(2):171-80. PubMed ID: 12887919
[TBL] [Abstract][Full Text] [Related]
36. A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen.
Meerovitch K; Bergeron F; Leblond L; Grouix B; Poirier C; Bubenik M; Chan L; Gourdeau H; Bowlin T; Attardo G
Vascul Pharmacol; 2003 Feb; 40(2):77-89. PubMed ID: 12646396
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
[TBL] [Abstract][Full Text] [Related]
38. Effects of collagen IV on neuroblastoma cell matrix-related functions.
Tzinia AK; Kitsiou PV; Talamagas AA; Georgopoulos A; Tsilibary EC
Exp Cell Res; 2002 Apr; 274(2):169-77. PubMed ID: 11900477
[TBL] [Abstract][Full Text] [Related]
39. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
[TBL] [Abstract][Full Text] [Related]
40. Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response.
Markowska AI; Liu FT; Panjwani N
J Exp Med; 2010 Aug; 207(9):1981-93. PubMed ID: 20713592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
